Literature DB >> 3114426

Striatal membrane-bound and soluble catechol-O-methyl-transferase after selective neuronal lesions in the rat.

S Kaakkola, P T Männistö, E Nissinen.   

Abstract

Activities of the two forms of catechol-O-methyltransferase (COMT), viz. the soluble (S-COMT) and the membrane-bound (MB-COMT), have been studied in the rat striatum to characterize their localization in relation to the nigrostriatal dopaminergic neurons. Selective unilateral nigrostriatal dopaminergic lesions were produced by an intranigral injection of 6-hydroxydopamine (6-OHDA; 8 micrograms/site). 6-OHDA caused an extensive lesion of the dopaminergic neurons as revealed by non-detectable concentrations of dopamine in the striata of the lesioned sites. In spite of that neither S-COMT nor MB-COMT activities were altered in comparison with the intact control striata. The intrastriatal injection of kainic acid significantly increased S-COMT activity but to some extent decreased MB-COMT activity. Kainic acid did not alter the striatal concentration of dopamine. These results suggest that both S-COMT and MB-COMT reside postsynaptically the nigrostriatal dopaminergic neurons. S-COMT seems to be found mainly in striatal glial cells, whereas striatal MB-COMT might be located both in postsynaptic neuronal and extraneuronal cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3114426     DOI: 10.1007/bf01244343

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  26 in total

1.  Catechol-O-methyl transferase and monoamine oxidase activity in cultured rodent astrocytoma cells.

Authors:  S D Silberstein; H M Shein; K R Berv
Journal:  Brain Res       Date:  1972-06-08       Impact factor: 3.252

2.  Presence of two distinct catechol -O- methyltransferase activities in red blood cells.

Authors:  M Assicot; C Bohuon
Journal:  Biochimie       Date:  1971       Impact factor: 4.079

3.  Factors affecting the enzymatic formation of O-methylated dihydroxy derivatives.

Authors:  J K Inscoe; J Daly; J Axelrod
Journal:  Biochem Pharmacol       Date:  1965-08       Impact factor: 5.858

4.  Presence of membrane-bound catechol-O-methyltransferase in human brain.

Authors:  J A Roth
Journal:  Biochem Pharmacol       Date:  1980-11-15       Impact factor: 5.858

5.  Catechol-O-methyltransferase in nerve endings of rat brain.

Authors:  M Alberici; E De Robertis
Journal:  Life Sci       Date:  1965-10       Impact factor: 5.037

6.  In situ injection of kainic acid: a new method for selectively lesioning neural cell bodies while sparing axons of passage.

Authors:  J T Coyle; M E Molliver; M J Kuhar
Journal:  J Comp Neurol       Date:  1978-07-15       Impact factor: 3.215

7.  Immunohistochemical demonstration of catechol-o-methyltransferase in mammalian brain.

Authors:  G P Kaplan; B K Hartman; C R Creveling
Journal:  Brain Res       Date:  1979-05-11       Impact factor: 3.252

8.  Characterization of membrane-bound and soluble catechol-O-methyltransferase from human frontal cortex.

Authors:  D R Jeffery; J A Roth
Journal:  J Neurochem       Date:  1984-03       Impact factor: 5.372

9.  Determination of catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection.

Authors:  E Nissinen; P Männistö
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

10.  Localization of membrane-bound catechol-O-methyltransferase.

Authors:  A J Rivett; A Francis; J A Roth
Journal:  J Neurochem       Date:  1983-05       Impact factor: 5.372

View more
  12 in total

Review 1.  Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine.

Authors:  M F Egan; S Chrapusta; F Karoum; B K Lipska; R J Wyatt
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein.

Authors:  Hoa A Lam; Nanping Wu; Ingrid Cely; Rachel L Kelly; Sindalana Hean; Franziska Richter; Iddo Magen; Carlos Cepeda; Larry C Ackerson; Wendy Walwyn; Eliezer Masliah; Marie-Françoise Chesselet; Michael S Levine; Nigel T Maidment
Journal:  J Neurosci Res       Date:  2011-04-12       Impact factor: 4.164

3.  Quantitative Analysis of Catecholamines in the Pink1 -/- Rat Model of Early-onset Parkinson's Disease.

Authors:  Cynthia A Kelm-Nelson; Michael A Trevino; Michelle R Ciucci
Journal:  Neuroscience       Date:  2018-02-27       Impact factor: 3.590

4.  Effect of S-COMT deficiency on behavior and extracellular brain dopamine concentrations in mice.

Authors:  Anne Tammimäki; Mikko Käenmäki; Oleg Kambur; Natalia Kulesskaya; Tiina Keisala; Eeva Karvonen; J Arturo García-Horsman; Heikki Rauvala; Pekka T Männistö
Journal:  Psychopharmacology (Berl)       Date:  2010-07-09       Impact factor: 4.530

Review 5.  Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease.

Authors:  Daphne Robakis; Stanley Fahn
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749

6.  Profound neuronal plasticity in response to inactivation of the dopamine transporter.

Authors:  S R Jones; R R Gainetdinov; M Jaber; B Giros; R M Wightman; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

7.  Expression of catechol-O-methyltransferase in the brain and periphery of normal and MPTP-treated common marmosets.

Authors:  Bai-Yun Zeng; Robert H Balfour; Mike J Jackson; Sarah Rose; Peter Jenner
Journal:  J Neural Transm (Vienna)       Date:  2009-09-22       Impact factor: 3.575

8.  Controlled cortical impact injury influences methylphenidate-induced changes in striatal dopamine neurotransmission.

Authors:  Amy K Wagner; Joshua E Sokoloski; Xiangbai Chen; Rashed Harun; Damian P Clossin; Amina S Khan; Meghan Andes-Koback; Adrian C Michael; C Edward Dixon
Journal:  J Neurochem       Date:  2009-05-08       Impact factor: 5.372

9.  Dopamine and its metabolites in cathepsin D heterozygous mice before and after MPTP administration.

Authors:  Donna Crabtree; Michaël Boyer-Guittaut; Xiaosen Ouyang; Naomi Fineberg; Jianhua Zhang
Journal:  Neurosci Lett       Date:  2013-02-04       Impact factor: 3.046

10.  Catechol-O-methyltransferase (COMT) protein expression and activity after dopaminergic and noradrenergic lesions of the rat brain.

Authors:  Nadia Schendzielorz; Juha-Pekka Oinas; Timo T Myöhänen; Ilkka Reenilä; Atso Raasmaja; Pekka T Männistö
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.